G1 Therapeutics, Inc.
NASDAQ:GTHX
7.16 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 32.281 | 94.594 | 221.186 | 207.306 | 269.208 | 369.29 | 103.812 | 47.305 | 22.938 | 3.694 |
| Short Term Investments
| 49.938 | 50.476 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 82.219 | 145.07 | 221.186 | 207.306 | 269.208 | 369.29 | 103.812 | 47.305 | 22.938 | 3.694 |
| Net Receivables
| 12.687 | 11.094 | 5.688 | 0.237 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 12.442 | 16.179 | 3.471 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 7.6 | 7.094 | 13.22 | 8.849 | 1.795 | 0.843 | 0.849 | 0.596 | 0.812 | 0.025 |
| Total Current Assets
| 114.948 | 179.5 | 243.565 | 216.392 | 271.003 | 370.133 | 104.661 | 47.901 | 23.75 | 3.719 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 6.384 | 7.951 | 9.048 | 10.508 | 13.391 | 1.137 | 0.51 | 0.311 | 0.147 | 0.103 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.187 | 0.25 | 0.312 | 0.437 | 0.437 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.021 | 0.264 | 1.169 | 1.215 | 0 | 0 | 0 | 0 | 0 | -0.103 |
| Total Non-Current Assets
| 6.592 | 8.465 | 10.529 | 12.16 | 13.828 | 1.137 | 0.51 | 0.311 | 0.147 | 0.103 |
| Total Assets
| 121.54 | 187.965 | 254.094 | 228.552 | 284.831 | 371.27 | 105.171 | 48.212 | 23.897 | 3.822 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 3.992 | 7.431 | 2.897 | 3.572 | 3.684 | 3.377 | 4.184 | 2.605 | 1.129 | 0.295 |
| Short Term Debt
| 1.276 | 1.135 | 1.115 | 16.486 | 0.682 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.62 | 0.007 | 0.031 | 0.237 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 23.828 | 27.015 | 23.57 | 3.148 | 15.403 | 8.985 | 7.52 | 3.021 | 1.039 | 0.052 |
| Total Current Liabilities
| 29.716 | 35.588 | 27.613 | 23.443 | 19.769 | 12.362 | 11.704 | 5.625 | 2.167 | 0.348 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 51.557 | 82.63 | 81.94 | 27.758 | 9.535 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 4.34 | -77.015 | -75.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.041 | 77.015 | 75.19 | 0 | 0 | 0.088 | 0.079 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 56.438 | 83.63 | 82.94 | 27.758 | 9.535 | 0.088 | 0.079 | 0 | 0 | 0 |
| Total Liabilities
| 86.154 | 119.218 | 110.553 | 51.201 | 29.304 | 12.45 | 11.783 | 5.625 | 2.167 | 0.348 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107.58 | 53.424 | 14.102 |
| Common Stock
| 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.003 | 0 | 0 | 0 |
| Retained Earnings
| -779.985 | -732.018 | -584.459 | -436.107 | -336.853 | -214.406 | -129.118 | -64.986 | -31.687 | -10.623 |
| Accumulated Other Comprehensive Income/Loss
| -0 | -0 | -0 | 0 | 0 | -0.322 | -0.181 | -0.107 | -0.069 | -0 |
| Other Total Stockholders Equity
| 815.366 | 800.76 | -0.004 | -0.004 | -0.004 | 0.318 | 222.684 | 0.099 | 0.061 | -0.005 |
| Total Shareholders Equity
| 35.386 | 68.747 | -584.459 | -436.107 | -336.853 | -214.406 | 93.388 | 42.587 | 21.729 | 3.474 |
| Total Equity
| 35.386 | 68.747 | -584.459 | -436.107 | -336.853 | -214.406 | 93.388 | 42.587 | 21.729 | 3.474 |
| Total Liabilities & Shareholders Equity
| 121.54 | 187.965 | -473.906 | -384.906 | -307.549 | -201.956 | 105.171 | 48.212 | 23.897 | 3.822 |